Episode 1: The Big C vs Big Communication - David Hunt, CEO, Havas Lynx, Keynote

On the 10th May we launched #LXAcademy 2018. In this keynote, David Hunt, CEO Havas Lynx, discusses The Big C vs Big Communication.

New treatments are revolutionising cancer care. Immune-based drugs are controlling advanced cancers in a way that's never before been possible. For those on the front line of treating cancer, there is a whole new level of excitement and opportunity, but also unprecedented complexity and uncertainty. And for patients, the fundamental realities of cancer treatment have changed and no longer match expectations. We are facing a new age of cancer. Not just a new age, but an entirely new vision. Communication has a critical role to play in ensuring the benefits of the ground-breaking treatments are realised for HCPs And patients alike.

SWITCHED ONcology is the latest thought leadership campaign from the award-winning Havas Lynx portfolio. The campaign is designed to combine science, creativity and technology in the delivery of communications that better support healthcare professionals, carers and ultimately patients on their journey with cancer. The campaign provides our partners with deeper insight, smarter ideas and more meaningful innovations, born out of an unprecedented investment into oncology.